Search

everythinglearnresearchcommunity

for

Search:↓

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

UV light makes skin signs of lack of carotene and vitamin A more visible.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Fucoidan-derived carbon dots can effectively treat root canal infections by killing bacteria and are safer than traditional disinfectants.

Suppressing ODC activity reduces tumor growth in hair follicles.

Adalimumab improved folliculitis decalvans in most patients.

Dupilumab may help regrow hair in people with atopic dermatitis.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

ODC transgenic mice can model human hair loss with skin lesions.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Avoiding exposure to certain grasses can prevent skin allergies, highlighting the importance of proper sanitation.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Dutasteride does not seem to change rat spermatogenesis or oxidative stress.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Cantú syndrome is caused by mutations in the ABCC9 gene.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.